Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease
Clinical trial NCT02197130 · COMPLETED
Trial details
- NCT number
- NCT02197130
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-09-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.